Cover Image
市場調查報告書

Atracurium的中國市場:2010年∼2019年

Investigation Report on China Atracurium Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 337524
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Atracurium的中國市場:2010年∼2019年 Investigation Report on China Atracurium Market, 2010-2019
出版日期: 2015年08月18日 內容資訊: 英文 30 Pages
簡介

根據中國政府的統計,2008年該國住院數是1億1500萬件,不過,2013年增加到1億9200萬件。還有其中大概4分之一接受手術。隨著手術數的增加,麻醉劑的需求也增加。Abbott及GlaxoSmithKline共同開發的Atracurium,是麻醉使用的肌肉鬆弛劑,還有Jiangsu Hengrui Medicine Co. Ltd企業製造了學名藥。

本報告提供中國的Atracurium的專利及核準情況、銷售額&銷售量的變化與預測、價格趨勢、主要的製藥公司與其市場佔有率、競爭環境與其展望、主要製造商的簡介等。

第1章 Atracurium的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國的Atracurium的市場簡介

  • 專利、核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國的Atracurium銷售情形

  • 銷售額
    • 總銷售額
    • 各地區的銷售額
  • 銷售量
    • 總銷售量
    • 各地區的銷售數

第4章 中國的主要Atracuriummeka的市場佔有率

  • 以銷售額為基礎的市場佔有率
  • 以銷售量為基礎的市場佔有率

第5章 中國的Atracurium的劑型相關調查

第6章 中國醫院的Atracurium標準價格

  • Jiangsu Hengrui Medicine Co., Ltd
  • Dong Ying (Jiangsu) Pharmaceutical Co., Ltd
  • GlaxoSmithKline (Italy)
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • Wellcome Trust (United Kingdom)
  • Shanghai Hengrui Pharmaceutical Co., Ltd

第7章 中國市場中Atracurium的主要製藥公司

  • Jiangsu Hengrui Medicine Co., Ltd
  • Dong Ying (Jiangsu) Pharmaceutical Co., Ltd
  • GlaxoSmithKline (Italy)
  • Zhejiang Xianju Pharmaceutical Co., Ltd

第8章 中國的Atracurium市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1508307

According to the Chinese government's statistics, the number of hospitalized cases rose from 115 million in 2008 to 192 million in 2013 with CAGR exceeding 8%, among which a quarter has to receive operation. As operation number keeps increasing, the demand for anaesthetic rises too.

Co-developed by Abbott and GlaxoSmithKline, atracurium is a muscle relaxant used in anesthesia whose generic drugs are also produced by such companies as Jiangsu Hengrui Medicine Co., Ltd. According to CRI's market survey, the sales value of atracurium in sample hospitals rose rapidly from less than CNY 20 million in 2005 to over CNY 200 million in 2014 and CAGR during this period reached 45.6%.

Jiangsu Hengrui, Dong Ying (Jiangsu) Pharmaceutical, GlaxoSmithKline (Italy) and Zhejiang Xianju Pharmaceutical Co., Ltd occupy the Chinese market, among which Jiangsu Hengrui reports an increasing share while Dong Ying (Jiangsu) Pharmaceutical and GlaxoSmithKline (Italy) report otherwise. And the price of atracurium products made by different companies vary from region to region and the price of imported atracurium is higher than its domestic counterpart.

As operation number keeps increasing in China, the demand for muscle relaxant used in anesthesia rises too. Therefore, atracurium enjoys a vast market in China.

Readers can get at least the following information through this report:

  • market size of atracurium in China
  • competitive landscape of atracurium market in China
  • price of atracurium made by different enterprises in China
  • market outlook of atracurium in China

The author suggests the following groups of people purchase this report:

  • drug makers
  • investors/research institutions interested in Chinese medicine market
  • -any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Atracurium

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Atracurium in China

  • 2.1. Patent and Approval Information of Atracurium in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Atracurium Sales in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Atracurium Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Atracurium in China, 2010-2014

6. Reference Price of Atracurium in Chinese Hospitals in 2014

  • 6.1. Jiangsu Hengrui Medicine Co., Ltd
  • 6.2. Dong Ying (Jiangsu) Pharmaceutical Co., Ltd
  • 6.3. GlaxoSmithKline (Italy)
  • 6.4. Zhejiang Xianju Pharmaceutical Co., Ltd
  • 6.5. Wellcome Trust (United Kingdom)
  • 6.6. Shanghai Hengrui Pharmaceutical Co., Ltd

7. Major Manufacturers of Atracurium in Chinese Market, 2010-2014

  • 7.1. Jiangsu Hengrui Medicine Co., Ltd
  • 7.2. Dong Ying (Jiangsu) Pharmaceutical Co., Ltd
  • 7.3. GlaxoSmithKline (Italy)
  • 7.4. Zhejiang Xianju Pharmaceutical Co., Ltd

8. Market Outlook of Atracurium in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Atracurium in China
  • Chart Approval Information of Atracurium in China
  • Chart Atracurium Sales in China
  • Chart Sales Value of Atracurium in China, 2010-2014
  • Chart Sales Value of Atracurium in Some Regions in China, 2010-2014
  • Chart Sales Volume of Atracurium in China, 2010-2014
  • Chart Sales Volume of Atracurium in Some Regions in China, 2010-2014
  • Chart Sales Value and Market Share of Atracurium Made by Jiangsu Hengrui in China, 2010-2014
  • Chart Sales Value and Market Share of Atracurium Made by Dong Ying (Jiangsu) Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Atracurium Made by GlaxoSmithKline (Italy) in China, 2010-2014
  • Chart Price of Atracurium Made by Jiangsu Hengrui Medicine Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Atracurium Made by Dong Ying (Jiangsu) Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Atracurium Made by GlaxoSmithKline (Italy) in Some Chinese Cities in 2014
  • Chart Price of Atracurium Made by Zhejiang Xianju Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Atracurium Made by Wellcome Trust (United Kingdom) in Some Chinese Cities in 2014
  • Chart Price of Atracurium Made by Jiangsu Hengrui Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top